“…By means of the strong antagonistic D 2 -A 2A receptor interaction at the adenylyl cyclase level, and due to the existence of a tonic effect of dopamine on D 2 receptors, under normal conditions A 2A receptors are practically unable to activate the cAMP-PKA signaling pathway (Agnati et al, 2003;Ferré et al, 2003Ferré et al, , 2004. In fact, the systemic administration of A 2A receptor antagonists produces either no effect or a modest decrease in the striatal expression of c-fos or preproenkephalin (Le Moine et al, 1997;Pinna et al, 1997;Aoyama et al, 2002;Carta et al, 2002;Karcz-Kubicha et al, 2003;Wardas et al, 2003). It must also be pointed out that some studies suggest that A 2A and D 2 receptor can interact synergistically, with stimulation of D 2 receptors potentiating the effects of A 2A receptor stimulation.…”